Global Health Future Growth
Future criteria checks 4/6
Global Health is forecast to grow earnings and revenue by 21.4% and 16.2% per annum respectively. EPS is expected to grow by 21% per annum. Return on equity is forecast to be 19.9% in 3 years.
Key information
21.4%
Earnings growth rate
21.0%
EPS growth rate
Healthcare earnings growth | 25.6% |
Revenue growth rate | 16.2% |
Future return on equity | 19.9% |
Analyst coverage | Good |
Last updated | 31 Jul 2024 |
Recent future growth updates
Global Health Limited (NSE:MEDANTA) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year
May 22Global Health Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Jun 01Recent updates
With EPS Growth And More, Global Health (NSE:MEDANTA) Makes An Interesting Case
Aug 02We Think Global Health (NSE:MEDANTA) Can Manage Its Debt With Ease
Jul 15Global Health Limited's (NSE:MEDANTA) Share Price Matching Investor Opinion
May 22Global Health Limited (NSE:MEDANTA) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year
May 22Returns On Capital Are Showing Encouraging Signs At Global Health (NSE:MEDANTA)
May 04Do Global Health's (NSE:MEDANTA) Earnings Warrant Your Attention?
Apr 12Is Global Health (NSE:MEDANTA) A Risky Investment?
Mar 22Market Participants Recognise Global Health Limited's (NSE:MEDANTA) Earnings Pushing Shares 32% Higher
Feb 13There's Been No Shortage Of Growth Recently For Global Health's (NSE:MEDANTA) Returns On Capital
Jan 18With EPS Growth And More, Global Health (NSE:MEDANTA) Makes An Interesting Case
Dec 26Global Health Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Jun 01Global Health Limited's (NSE:MEDANTA) Earnings Haven't Escaped The Attention Of Investors
Mar 30Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 53,510 | 9,093 | 6,928 | 11,327 | 4 |
3/31/2026 | 46,000 | 7,818 | 4,890 | 10,019 | 8 |
3/31/2025 | 38,122 | 6,026 | 3,143 | 8,334 | 9 |
3/31/2024 | 32,751 | 4,782 | 3,335 | 6,121 | N/A |
12/31/2023 | 31,660 | 4,519 | N/A | N/A | N/A |
9/30/2023 | 30,277 | 4,089 | 4,024 | 6,400 | N/A |
6/30/2023 | 28,498 | 3,694 | N/A | N/A | N/A |
3/31/2023 | 27,072 | 3,261 | 4,085 | 6,445 | N/A |
12/31/2022 | 25,164 | 2,426 | N/A | N/A | N/A |
6/30/2022 | 23,043 | 2,132 | 1,109 | 3,724 | N/A |
3/31/2022 | 21,725 | 1,962 | 368 | 3,113 | N/A |
3/31/2021 | 14,519 | 288 | 960 | 2,418 | N/A |
3/31/2020 | 15,182 | 363 | -132 | 1,751 | N/A |
3/31/2019 | 14,782 | 610 | -1,496 | 1,501 | N/A |
3/31/2018 | 13,677 | 329 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MEDANTA's forecast earnings growth (21.4% per year) is above the savings rate (6.7%).
Earnings vs Market: MEDANTA's earnings (21.4% per year) are forecast to grow faster than the Indian market (16.4% per year).
High Growth Earnings: MEDANTA's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: MEDANTA's revenue (16.2% per year) is forecast to grow faster than the Indian market (9.7% per year).
High Growth Revenue: MEDANTA's revenue (16.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MEDANTA's Return on Equity is forecast to be low in 3 years time (19.9%).